The process by which institutional review boards oversee clinical trials needs reforms that are “big and different” so that the US can keep pace with

Plus, news about Bayer’s Kerendia, Eli Lilly’s Ebglyss and Alto Neuroscience: 📈 CytomX’s colorectal cancer data: The biotech tested multiple doses of its antibody-drug conjugate

AstraZeneca’s cancer immunotherapy Imfinzi has been approved in the EU for use before and after surgery for early-stage gastric cancer.

CirCode Biomed, a Chinese startup working on an experimental class of genetic medicines known as circular RNA, has received the FDA’s blessing to begin a

A German study has stoked debate about the merits of screening for prostate cancer, which is lagging behind breast cancer screening in Europe.